ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,000 | -76.0% | 16,000 | -79.1% | 0.00% | – |
| Q1 2022 | $100,000 | -62.8% | 76,637 | -50.0% | 0.00% | – |
| Q4 2021 | $269,000 | -44.8% | 153,337 | -31.8% | 0.00% | -100.0% |
| Q3 2021 | $487,000 | -38.1% | 224,790 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $787,000 | -0.4% | 225,318 | +180.9% | 0.00% | 0.0% |
| Q1 2021 | $790,000 | -9.1% | 80,227 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $869,000 | -28.2% | 80,227 | -31.9% | 0.00% | -33.3% |
| Q3 2020 | $1,211,000 | +37.1% | 117,861 | +177.8% | 0.00% | +50.0% |
| Q2 2020 | $883,000 | +203.4% | 42,425 | +42.3% | 0.00% | +100.0% |
| Q1 2020 | $291,000 | +164.5% | 29,813 | +44.0% | 0.00% | – |
| Q2 2018 | $110,000 | -16.7% | 20,700 | -8.8% | 0.00% | – |
| Q1 2018 | $132,000 | -31.6% | 22,700 | -57.7% | 0.00% | – |
| Q4 2017 | $193,000 | -19.9% | 53,657 | -18.7% | 0.00% | – |
| Q3 2017 | $241,000 | – | 65,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 178,654 | $652,000 | 0.48% |
| EcoR1 Capital, LLC | 762,947 | $2,785,000 | 0.37% |
| VHCP Management II, LLC | 280,000 | $1,022,000 | 0.28% |
| MANGROVE PARTNERS IM, LLC | 413,838 | $1,511,000 | 0.26% |
| Sessa Capital IM, L.P. | 638,712 | $2,331,000 | 0.26% |
| 683 Capital Management, LLC | 550,000 | $2,008,000 | 0.21% |
| Rhenman & Partners Asset Management AB | 154,006 | $562,000 | 0.07% |
| ELEMENT CAPITAL MANAGEMENT LLC | 35,346 | $129,000 | 0.05% |
| Tekla Capital Management LLC | 300,078 | $1,095,000 | 0.04% |
| Marquette Asset Management, LLC | 25,998 | $95,000 | 0.04% |